Bokf Na trimmed its holdings in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 14.1% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 40,469 shares of the company’s stock after selling 6,670 shares during the quarter. Bokf Na’s holdings in Option Care Health were worth $1,121,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in OPCH. Westfield Capital Management Co. LP increased its stake in shares of Option Care Health by 19.6% in the fourth quarter. Westfield Capital Management Co. LP now owns 4,482,732 shares of the company’s stock worth $151,023,000 after buying an additional 735,344 shares during the period. Schroder Investment Management Group increased its stake in shares of Option Care Health by 7.3% in the fourth quarter. Schroder Investment Management Group now owns 1,417,591 shares of the company’s stock worth $47,759,000 after buying an additional 96,587 shares during the period. Congress Asset Management Co. MA increased its stake in shares of Option Care Health by 37.2% in the fourth quarter. Congress Asset Management Co. MA now owns 203,569 shares of the company’s stock worth $6,858,000 after buying an additional 55,233 shares during the period. Harbor Capital Advisors Inc. increased its stake in shares of Option Care Health by 317.9% in the second quarter. Harbor Capital Advisors Inc. now owns 96,375 shares of the company’s stock worth $2,670,000 after buying an additional 73,312 shares during the period. Finally, Teachers Retirement System of The State of Kentucky increased its position in Option Care Health by 40.9% during the 4th quarter. Teachers Retirement System of The State of Kentucky now owns 394,254 shares of the company’s stock valued at $13,282,000 after purchasing an additional 114,509 shares during the period. 98.05% of the stock is currently owned by institutional investors.
Option Care Health Stock Performance
Shares of OPCH stock opened at $31.99 on Monday. Option Care Health, Inc. has a 12 month low of $26.11 and a 12 month high of $35.24. The stock has a market cap of $5.56 billion, a PE ratio of 21.05, a price-to-earnings-growth ratio of 2.46 and a beta of 1.29. The company has a current ratio of 1.76, a quick ratio of 1.36 and a debt-to-equity ratio of 0.78. The company’s fifty day moving average price is $30.84 and its 200-day moving average price is $30.48.
Insider Activity
In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Michael H. Shapiro sold 23,217 shares of the stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. The disclosure for this sale can be found here. Company insiders own 0.64% of the company’s stock.
Wall Street Analyst Weigh In
OPCH has been the topic of a number of research analyst reports. JMP Securities initiated coverage on shares of Option Care Health in a research report on Tuesday, July 16th. They set an “outperform” rating and a $36.00 price objective on the stock. Barrington Research boosted their price objective on shares of Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a research report on Thursday, August 1st.
Read Our Latest Stock Analysis on OPCH
Option Care Health Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Further Reading
- Five stocks we like better than Option Care Health
- How to Invest in the FAANG Stocks
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- Investing In Preferred Stock vs. Common Stock
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- Earnings Per Share Calculator: How to Calculate EPS
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.